To rule out off-target effects of a particular ATR inhibitor, we confirmed the effects of ATR inhibition using a different ATR inhibitor in our lung cancer models for clonogenic cell survival and RAD51 foci formation. The gene discussed is RAD51; the disease is lung cancer.